Why pulling the same 'levers' on reform cannot work. Comparing one medicines access program and its humanitarian underpinnings to our institutional frameworks. The need for term limits on advisory committees, the enduring unfairness of medicine co-payments, and the phrase of the week.
-
Latest News
Patients Australia puts healthcare’s quiet achievers in the spotlight
Across 15 categories, the winners included clinicians, organisations, researchers, advocates and services whose work has made healthcare more accessible, humane and responsive to the people at its centre.
-
Podcast The 'Dispatched' Week in Review Podcast - Series 5. Ep.30 August 28, 2026
-
BioPharma Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health August 28, 2026Weight loss medicines are emerging as a major sales driver for Australia’s major wholesalers and pharmacy operators, with both Sigma Healthcare and Wesfarmers Health citing strong demand for GLP-1 treatments as a contributor to revenue growth.
-
Latest News Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients August 28, 2026Without further action, the Pharmacy Guild says the $25 general co-payment will resume annual indexation from January 1, 2027, putting it on track to reach about $30 by the end of the decade.
-
Latest News Sandoz earns workplace recognition amid push for medicine access August 28, 2026Sandoz Australia and New Zealand has been named among Australia’s Top 100 Best Workplaces for 2026, ranking 15th in the medium-sized business category and standing as the only pharmaceutical company included in that division.
-
Latest News Mayne Pharma bets on women’s health and direct distribution after a difficult year August 28, 2026Mayne Pharma has emerged from a difficult year with a sharper focus on women’s health, direct-to-patient dispensing, and manufacturing growth, despite lower revenue and earnings.
-
Latest News Cathy Freeman to headline 2026 Patient’s Choice Awards August 27, 2026Olympic champion and Australian icon Cathy Freeman will be the guest of honour at tonight's 2026 Patient’s Choice Awards, a national celebration of the people and organisations helping to make healthcare more compassionate, responsive and centred on the needs of patients.
-
Latest News Australian company secures Mitsubishi partnership to bring BioPQQ to market August 26, 2026Chief executive and co-founder Sally Panton said the Mitsubishi partnership was an important vote of confidence in the company’s ambitions to build a regulated cellular-health platform with international reach.
-
Australian Biotech Genetic Signatures and Microba explore merger to build infectious disease diagnostics group August 26, 2026Genetic Signatures and Microba Life Sciences have announced they are in preliminary discussions about a potential merger that would combine rapid infectious disease testing with gut microbiome profiling and create a larger ASX-listed diagnostics business.
-
Latest News Australia cannot deliver meaningful change until the levers of power are rebalanced August 26, 2026Any assessment of Australia’s use of health technology assessment requires an historical lens, at the very least for context, but also for learnings. The system's history makes it predictable. It is how we know what comes next.
-
Latest News Australian company secures European approval for rare disease treatment August 26, 2026Chief executive Jon Pilcher said the approval was especially meaningful given the lack of an approved Rett syndrome treatment in Europe to date.
-
Latest News Professor Brandon Wainwright appointed to lead QIMR Berghofer August 25, 2026QIMR Berghofer, one of Australia's leading medical research institutions, has appointed internationally recognised geneticist Professor Brandon Wainwright AM as its next Director and Chief Executive Officer.
-
Latest News Australian study finds maternal RSV vaccination offers strong protection for infants August 25, 2026Dr Krishan Thiru, Medical Director for Pfizer Australia and New Zealand, said the results provide important local evidence at a time when infants face their greatest risk of severe RSV disease.
-
Latest News Insurers warn cut could hit Australians most likely to need cancer care August 25, 2026The organisation has pointed to the potential impact on cancer treatment and care, highlighting that the policyholders impacted by the reduction are more likely than any other age group to access cancer treatment.
-
Australian Biotech Acrux brings experienced clinical leader aboard to advance testosterone program August 24, 2026Acrux has appointed physician and biopharmaceutical executive Dr Jolanta Airey as its chief medical officer, strengthening its leadership team as it prepares to advance its female testosterone treatment toward Phase 3 clinical trials in the United States.
-
Latest News These rarely stated realities should be discussed in the open more often August 24, 2026At the congress, an experienced PBAC member offered a rare glimpse inside Australia’s medicines-reimbursement institution. It was imperfect in its facts, but critically important and worth welcoming, particularly the comments about patient input and the 'reality' of the 'emotive pull' of cancer.
-
Latest News July recommendations across oncology, rare disease and chronic care August 24, 2026At its July meeting, the committee backed multiple submissions but rejected or deferred others for the regularly cited reasons, including pricing.
-
Latest News The claim Australia cannot invest more in new medicines fails very quickly August 24, 2026The Government's own projections for one sub-program of the National Disability Insurance Scheme show that Australia can afford a more ambitious investment in new medicines. It is a choice.
-
Latest News Opportunity #5 - From the hardest thing to secure to the easiest thing to get right August 21, 2026As the medicines industry prepares to negotiate new agreements with the Commonwealth, the one thing it must get right is the easiest to understand. That is, power dependence.
-
Latest News Opportunity #4 - Scope creep demands stronger checks and balances August 19, 2026Opportunity number four for industry in the pending negotiation of new agreements may be the hardest to achieve, but it also offers the greatest potential to put Australia’s medicines decision-making framework on track.
Australian Biotech
-
Australian company secures Mitsubishi partnership to bring BioPQQ to market
August 26, 2026 -
Noxopharm pushes Sofra platform towards cancer proof of concept
August 26, 2026 -
Neuren’s first dividend signals a new phase built on DAYBUE royalties
August 26, 2026 -
Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway
August 26, 2026 -
Genetic Signatures and Microba explore merger to build infectious disease diagnostics group
August 26, 2026
Other Health
-
Rare autoimmune diseases impose a $1.2 billion annual burden on Australians
August 20, 2026 -
New partnership aims to create national blueprint for earlier Alzheimer’s diagnosis and care
July 31, 2026 -
Melbourne study links higher tumour radiation dose to longer progression-free survival
July 10, 2026 -
Tax deal delays NDIS overhaul and reopens scrutiny with inquiry extension
June 24, 2026 -
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - Series 5. Ep.30
August 28, 2026 - - Podcast -
Sandoz earns workplace recognition amid push for medicine access
August 28, 2026 - - Latest News -
Cheaper medicines save Australians $1.4 billion as pharmacists urge freeze for all patients
August 28, 2026 - - Latest News -
Mayne Pharma bets on women’s health and direct distribution after a difficult year
August 28, 2026 - - Latest News -
Patients Australia puts healthcare’s quiet achievers in the spotlight
August 28, 2026 - - Latest News -
Weight loss medicines drive revenue growth for Sigma and Wesfarmers Health
August 28, 2026 - - BioPharma -
Cathy Freeman to headline 2026 Patient’s Choice Awards
August 27, 2026 - - Latest News